Sepsis Tied to Higher Post-Discharge Mortality Risk

Share this content:
Sepsis Tied to Higher Post-Discharge Mortality Risk
Sepsis Tied to Higher Post-Discharge Mortality Risk

TUESDAY, Feb. 9, 2016 (HealthDay News) -- Sepsis survivors have a substantially increased risk of all-cause mortality and major adverse cardiovascular events after discharge, according to a study published online Jan. 25 in the American Journal of Respiratory and Critical Care Medicine.

Shuo-Ming Ou, M.D., from the Taipei Veterans General Hospital in Taiwan, and colleagues analyzed data from a nationwide population database to identify patients with sepsis from 2000 to 2002. Sepsis survivors were propensity-matched (1-to-1) to control subjects from the general population and control subjects who were hospitalized for a nonsepsis diagnosis.

The researchers found that sepsis survivors had higher risks of all-cause mortality (hazard ratio [HR], 2.18), major adverse cardiovascular events (HR, 1.37), ischemic stroke (HR, 1.27), hemorrhagic stroke (HR, 1.36), myocardial infarction (HR, 1.22), heart failure (HR, 1.48), and sudden cardiac death or ventricular arrhythmia (HR, 1.65) compared with controls in the general population. Similar results, although with slightly lower risks, were seen when sepsis survivors were compared with nonsepsis hospitalized controls.

"These data indicate that sepsis survivors had substantially increased risks of subsequent all-cause mortality and major adverse cardiovascular events at one year after discharge, which persisted for up to five years after discharge," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »